Supporting its role in the pathophysiology of depression, lower serum BDNF concentrations have been reported in many studies of patients with major depression (Çakici et al., 2020) and increased expression of BDNF has been implicated as one of the mechanisms underlying antidepressant drugs (Castrén and Monteggia, 2021). Here, BDNF is linked to depressive symptom measurement.